Fox Run Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Fox Run Management's AMGN Position: Q3 2025 in Review
Fox Run Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 2,530 shares — an estimated $706K sold.
Fox Run Management first reported a position in AMGN in Q2 2016 and held it in 16 quarters. The position peaked at $1.29M in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Fox Run Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Fox Run Management sold 2,530 Amgen shares in Q3 2025, an estimated $706K.
- Fox Run Management first reported a position in Amgen in Q2 2016 and held it in 16 quarters.
- Fox Run Management's Amgen position peaked at $1.29M in Q3 2024.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.